Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Drug Delivery Insights: Nanotechnology and Microspheres

August 1, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Nanolipogels for anticancer drug delivery, inhalable and thermo-responsive, fat-encased nanoparticles for targeted drug delivery, and calcium carbonate microspheres are some recent developments.

Medicines Top EU's Counterfeit List

July 30, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

A report from the European Commission shows that fake pharmaceuticals were the top articles detained by European Union customs in 2011.

AstraZeneca Restructures Vaccines R&D and Operations

July 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

MedImmune, the global biologics arm of AstraZeneca, announced that it is restructuring its infectious disease and vaccines R&D and operations. This will result in the closure of MedImmune's sites in Mountain View and Santa Clara, California.

Sandoz Completes Acquisition of Generic Dermatology Company Fougera for $1.5 billion

July 23, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Sandoz announced it has completed the acquisition of Fougera Pharmaceuticals, a maker of generic dermatology products, for $1.5 billion.

A Look into the Future: The Pharmaceutical Company of 2020

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

How will the pharmaceutical company of 2020 be different from the pharmaceutical company of 2010? A look at emerging business models and the factors influencing the direction of the global pharmaceutical industry.

Biosimilars: Market Weaknesses and Strengths

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Biosimilars represent an emerging niche in the biopharmaceutical market, but how strong is their true potential?

Decades of Change for the Top Pharmaceutical Companies

July 11, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Tracking change from spinoffs of chemical companies to life-sciences powerhouses.

Congress Passes Generic Drug Act

July 10, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

On July 9, 2012, Congress passed the Generic Drug User Fee Act in an effort to expedite the process of bringing generic drugs to market. The Act authorizes the collection of user fees from generic-drug manufacturing companies for the first time in the industry's history.

ISPE Issues Guidance for Packaging, Labeling, and Warehousing Facilities

July 9, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

ISPE has issued a guidance that is intended to help companies meet cGMP requirements for packaging, labeling, and warehousing facilities and avoid problems such as product adulteration, product mix-up, label mix-up, and misbranding.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
42%
No government involvement in patient treatment or drug development.
12%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here